SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: tom pope who wrote (4195)6/25/2001 11:05:46 AM
From: Michael Young  Respond to of 52153
 
It does seem the FDA is going back to its old ways. Not sure what the excuses are this time. Lack of funding? Pressure from interest groups?

It obviously isn't good news for valuations in the sector when the FDA rejects/delays drugs with good trial data.

MIKE